aluates Reports

$ 0.0

Automative

Global Eftrenonacog Alfa Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-39R12373

Global Eftrenonacog Alfa Market Research Report 2022

BUY CHAPTERS

Global Eftrenonacog Alfa Market Research Report 2025

Code: QYRE-Auto-39R12373

Report

March 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Vetter Pharma-Fertigung GmbH & Co. KG

Sanofi Aventis

Biogen

Swedish Orphan Biovitrum AB

Bioverativ Therapeutics Inc.

Eftrenonacog Alfa Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Eftrenonacog Alfa Market

The global market for Eftrenonacog Alfa was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Eftrenonacog alfa is a long-acting recombinant fusion protein used in the treatment of hemophilia B. It is comprised of a single molecule of human factor IX (FIX) covalently linked to the constant region (Fc) domain of human IgG1 via recombinant DNA technology in a human embryonic kidney cell line (HEK293H) 1. The presence of the Fc domain extends the terminal half-life which confers clinical benefits of prolonged therapeutic efficacy, less frequent intravenous injections for patient convenience and improved adherence to prophylaxis.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Eftrenonacog Alfa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eftrenonacog Alfa.

The Eftrenonacog Alfa market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eftrenonacog Alfa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Eftrenonacog Alfa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Eftrenonacog Alfa Market Report

Report Metric	Details
Report Name	Eftrenonacog Alfa Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	250IU 500IU 1000IU 2000IU
Segment by Application	Hemophilia Surgical Bleeding Long-term Bleeding Prevention
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Vetter Pharma-Fertigung GmbH & Co.KG, Sanofi Aventis, Bioverativ Therapeutics Inc., Biogen Inc, SWEDISH ORPHAN BIOVITRUM AB
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eftrenonacog Alfa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eftrenonacog Alfa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Eftrenonacog Alfa Market report?

Ans: The main players in the Eftrenonacog Alfa Market are Vetter Pharma-Fertigung GmbH & Co.KG, Sanofi Aventis, Bioverativ Therapeutics Inc., Biogen Inc, SWEDISH ORPHAN BIOVITRUM AB

What are the Application segmentation covered in the Eftrenonacog Alfa Market report?

Ans: The Applications covered in the Eftrenonacog Alfa Market report are Hemophilia, Surgical Bleeding, Long-term Bleeding Prevention

What are the Type segmentation covered in the Eftrenonacog Alfa Market report?

Ans: The Types covered in the Eftrenonacog Alfa Market report are 250IU, 500IU, 1000IU, 2000IU

Recommended Reports

Hemostasis Devices

Blood & Clotting

Surgical Equipment

1 Eftrenonacog Alfa Market Overview

1.1 Product Definition

1.2 Eftrenonacog Alfa by Type

1.2.1 Global Eftrenonacog Alfa Market Value Comparison by Type (2024 VS 2031)

1.2.2 250IU

1.2.3 500IU

1.2.4 1000IU

1.2.5 2000IU

1.3 Eftrenonacog Alfa by Application

1.3.1 Global Eftrenonacog Alfa Market Value by Application (2024 VS 2031)

1.3.2 Hemophilia

1.3.3 Surgical Bleeding

1.3.4 Long-term Bleeding Prevention

1.4 Global Eftrenonacog Alfa Market Size Estimates and Forecasts

1.4.1 Global Eftrenonacog Alfa Revenue 2020-2031

1.4.2 Global Eftrenonacog Alfa Sales 2020-2031

1.4.3 Global Eftrenonacog Alfa Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Eftrenonacog Alfa Market Competition by Manufacturers

2.1 Global Eftrenonacog Alfa Sales Market Share by Manufacturers (2020-2025)

2.2 Global Eftrenonacog Alfa Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Eftrenonacog Alfa Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Eftrenonacog Alfa, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Eftrenonacog Alfa, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Eftrenonacog Alfa, Product Type & Application

2.7 Global Key Manufacturers of Eftrenonacog Alfa, Date of Enter into This Industry

2.8 Global Eftrenonacog Alfa Market Competitive Situation and Trends

2.8.1 Global Eftrenonacog Alfa Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Eftrenonacog Alfa Players Market Share by Revenue

2.8.3 Global Eftrenonacog Alfa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Eftrenonacog Alfa Market Scenario by Region

3.1 Global Eftrenonacog Alfa Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Eftrenonacog Alfa Sales by Region: 2020-2031

3.2.1 Global Eftrenonacog Alfa Sales by Region: 2020-2025

3.2.2 Global Eftrenonacog Alfa Sales by Region: 2026-2031

3.3 Global Eftrenonacog Alfa Revenue by Region: 2020-2031

3.3.1 Global Eftrenonacog Alfa Revenue by Region: 2020-2025

3.3.2 Global Eftrenonacog Alfa Revenue by Region: 2026-2031

3.4 North America Eftrenonacog Alfa Market Facts & Figures by Country

3.4.1 North America Eftrenonacog Alfa Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Eftrenonacog Alfa Sales by Country (2020-2031)

3.4.3 North America Eftrenonacog Alfa Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Eftrenonacog Alfa Market Facts & Figures by Country

3.5.1 Europe Eftrenonacog Alfa Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Eftrenonacog Alfa Sales by Country (2020-2031)

3.5.3 Europe Eftrenonacog Alfa Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Eftrenonacog Alfa Market Facts & Figures by Region

3.6.1 Asia Pacific Eftrenonacog Alfa Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Eftrenonacog Alfa Sales by Region (2020-2031)

3.6.3 Asia Pacific Eftrenonacog Alfa Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Eftrenonacog Alfa Market Facts & Figures by Country

3.7.1 Latin America Eftrenonacog Alfa Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Eftrenonacog Alfa Sales by Country (2020-2031)

3.7.3 Latin America Eftrenonacog Alfa Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Eftrenonacog Alfa Market Facts & Figures by Country

3.8.1 Middle East and Africa Eftrenonacog Alfa Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Eftrenonacog Alfa Sales by Country (2020-2031)

3.8.3 Middle East and Africa Eftrenonacog Alfa Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Eftrenonacog Alfa Sales by Type (2020-2031)

4.1.1 Global Eftrenonacog Alfa Sales by Type (2020-2025)

4.1.2 Global Eftrenonacog Alfa Sales by Type (2026-2031)

4.1.3 Global Eftrenonacog Alfa Sales Market Share by Type (2020-2031)

4.2 Global Eftrenonacog Alfa Revenue by Type (2020-2031)

4.2.1 Global Eftrenonacog Alfa Revenue by Type (2020-2025)

4.2.2 Global Eftrenonacog Alfa Revenue by Type (2026-2031)

4.2.3 Global Eftrenonacog Alfa Revenue Market Share by Type (2020-2031)

4.3 Global Eftrenonacog Alfa Price by Type (2020-2031)

5 Segment by Application

5.1 Global Eftrenonacog Alfa Sales by Application (2020-2031)

5.1.1 Global Eftrenonacog Alfa Sales by Application (2020-2025)

5.1.2 Global Eftrenonacog Alfa Sales by Application (2026-2031)

5.1.3 Global Eftrenonacog Alfa Sales Market Share by Application (2020-2031)

5.2 Global Eftrenonacog Alfa Revenue by Application (2020-2031)

5.2.1 Global Eftrenonacog Alfa Revenue by Application (2020-2025)

5.2.2 Global Eftrenonacog Alfa Revenue by Application (2026-2031)

5.2.3 Global Eftrenonacog Alfa Revenue Market Share by Application (2020-2031)

5.3 Global Eftrenonacog Alfa Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Vetter Pharma-Fertigung GmbH & Co.KG

6.1.1 Vetter Pharma-Fertigung GmbH & Co.KG Company Information

6.1.2 Vetter Pharma-Fertigung GmbH & Co.KG Description and Business Overview

6.1.3 Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Product Portfolio

6.1.5 Vetter Pharma-Fertigung GmbH & Co.KG Recent Developments/Updates

6.2 Sanofi Aventis

6.2.1 Sanofi Aventis Company Information

6.2.2 Sanofi Aventis Description and Business Overview

6.2.3 Sanofi Aventis Eftrenonacog Alfa Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sanofi Aventis Eftrenonacog Alfa Product Portfolio

6.2.5 Sanofi Aventis Recent Developments/Updates

6.3 Bioverativ Therapeutics Inc.

6.3.1 Bioverativ Therapeutics Inc. Company Information

6.3.2 Bioverativ Therapeutics Inc. Description and Business Overview

6.3.3 Bioverativ Therapeutics Inc. Eftrenonacog Alfa Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bioverativ Therapeutics Inc. Eftrenonacog Alfa Product Portfolio

6.3.5 Bioverativ Therapeutics Inc. Recent Developments/Updates

6.4 Biogen Inc

6.4.1 Biogen Inc Company Information

6.4.2 Biogen Inc Description and Business Overview

6.4.3 Biogen Inc Eftrenonacog Alfa Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Biogen Inc Eftrenonacog Alfa Product Portfolio

6.4.5 Biogen Inc Recent Developments/Updates

6.5 SWEDISH ORPHAN BIOVITRUM AB

6.5.1 SWEDISH ORPHAN BIOVITRUM AB Company Information

6.5.2 SWEDISH ORPHAN BIOVITRUM AB Description and Business Overview

6.5.3 SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Sales, Revenue and Gross Margin (2020-2025)

6.5.4 SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Product Portfolio

6.5.5 SWEDISH ORPHAN BIOVITRUM AB Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Eftrenonacog Alfa Industry Chain Analysis

7.2 Eftrenonacog Alfa Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Eftrenonacog Alfa Production Mode & Process Analysis

7.4 Eftrenonacog Alfa Sales and Marketing

7.4.1 Eftrenonacog Alfa Sales Channels

7.4.2 Eftrenonacog Alfa Distributors

7.5 Eftrenonacog Alfa Customer Analysis

8 Eftrenonacog Alfa Market Dynamics

8.1 Eftrenonacog Alfa Industry Trends

8.2 Eftrenonacog Alfa Market Drivers

8.3 Eftrenonacog Alfa Market Challenges

8.4 Eftrenonacog Alfa Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Vetter Pharma-Fertigung GmbH & Co. KG

Sanofi Aventis

Biogen

Swedish Orphan Biovitrum AB

Bioverativ Therapeutics Inc.

List of Tables

Table 1. Global Eftrenonacog Alfa Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Eftrenonacog Alfa Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Eftrenonacog Alfa Market Competitive Situation by Manufacturers in 2024

Table 4. Global Eftrenonacog Alfa Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Eftrenonacog Alfa Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Eftrenonacog Alfa Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Eftrenonacog Alfa Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Eftrenonacog Alfa Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Eftrenonacog Alfa, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Eftrenonacog Alfa, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Eftrenonacog Alfa, Product Type & Application

Table 12. Global Key Manufacturers of Eftrenonacog Alfa, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Eftrenonacog Alfa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eftrenonacog Alfa as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Eftrenonacog Alfa Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Eftrenonacog Alfa Sales by Region (2020-2025) & (K Units)

Table 18. Global Eftrenonacog Alfa Sales Market Share by Region (2020-2025)

Table 19. Global Eftrenonacog Alfa Sales by Region (2026-2031) & (K Units)

Table 20. Global Eftrenonacog Alfa Sales Market Share by Region (2026-2031)

Table 21. Global Eftrenonacog Alfa Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Eftrenonacog Alfa Revenue Market Share by Region (2020-2025)

Table 23. Global Eftrenonacog Alfa Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Eftrenonacog Alfa Revenue Market Share by Region (2026-2031)

Table 25. North America Eftrenonacog Alfa Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Eftrenonacog Alfa Sales by Country (2020-2025) & (K Units)

Table 27. North America Eftrenonacog Alfa Sales by Country (2026-2031) & (K Units)

Table 28. North America Eftrenonacog Alfa Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Eftrenonacog Alfa Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Eftrenonacog Alfa Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Eftrenonacog Alfa Sales by Country (2020-2025) & (K Units)

Table 32. Europe Eftrenonacog Alfa Sales by Country (2026-2031) & (K Units)

Table 33. Europe Eftrenonacog Alfa Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Eftrenonacog Alfa Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Eftrenonacog Alfa Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Eftrenonacog Alfa Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Eftrenonacog Alfa Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Eftrenonacog Alfa Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Eftrenonacog Alfa Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Eftrenonacog Alfa Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Eftrenonacog Alfa Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Eftrenonacog Alfa Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Eftrenonacog Alfa Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Eftrenonacog Alfa Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Eftrenonacog Alfa Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Eftrenonacog Alfa Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Eftrenonacog Alfa Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Eftrenonacog Alfa Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Eftrenonacog Alfa Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Eftrenonacog Alfa Sales (K Units) by Type (2020-2025)

Table 51. Global Eftrenonacog Alfa Sales (K Units) by Type (2026-2031)

Table 52. Global Eftrenonacog Alfa Sales Market Share by Type (2020-2025)

Table 53. Global Eftrenonacog Alfa Sales Market Share by Type (2026-2031)

Table 54. Global Eftrenonacog Alfa Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Eftrenonacog Alfa Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Eftrenonacog Alfa Revenue Market Share by Type (2020-2025)

Table 57. Global Eftrenonacog Alfa Revenue Market Share by Type (2026-2031)

Table 58. Global Eftrenonacog Alfa Price (US$/Unit) by Type (2020-2025)

Table 59. Global Eftrenonacog Alfa Price (US$/Unit) by Type (2026-2031)

Table 60. Global Eftrenonacog Alfa Sales (K Units) by Application (2020-2025)

Table 61. Global Eftrenonacog Alfa Sales (K Units) by Application (2026-2031)

Table 62. Global Eftrenonacog Alfa Sales Market Share by Application (2020-2025)

Table 63. Global Eftrenonacog Alfa Sales Market Share by Application (2026-2031)

Table 64. Global Eftrenonacog Alfa Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Eftrenonacog Alfa Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Eftrenonacog Alfa Revenue Market Share by Application (2020-2025)

Table 67. Global Eftrenonacog Alfa Revenue Market Share by Application (2026-2031)

Table 68. Global Eftrenonacog Alfa Price (US$/Unit) by Application (2020-2025)

Table 69. Global Eftrenonacog Alfa Price (US$/Unit) by Application (2026-2031)

Table 70. Vetter Pharma-Fertigung GmbH & Co.KG Company Information

Table 71. Vetter Pharma-Fertigung GmbH & Co.KG Description and Business Overview

Table 72. Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Vetter Pharma-Fertigung GmbH & Co.KG Eftrenonacog Alfa Product

Table 74. Vetter Pharma-Fertigung GmbH & Co.KG Recent Developments/Updates

Table 75. Sanofi Aventis Company Information

Table 76. Sanofi Aventis Description and Business Overview

Table 77. Sanofi Aventis Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Sanofi Aventis Eftrenonacog Alfa Product

Table 79. Sanofi Aventis Recent Developments/Updates

Table 80. Bioverativ Therapeutics Inc. Company Information

Table 81. Bioverativ Therapeutics Inc. Description and Business Overview

Table 82. Bioverativ Therapeutics Inc. Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Bioverativ Therapeutics Inc. Eftrenonacog Alfa Product

Table 84. Bioverativ Therapeutics Inc. Recent Developments/Updates

Table 85. Biogen Inc Company Information

Table 86. Biogen Inc Description and Business Overview

Table 87. Biogen Inc Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Biogen Inc Eftrenonacog Alfa Product

Table 89. Biogen Inc Recent Developments/Updates

Table 90. SWEDISH ORPHAN BIOVITRUM AB Company Information

Table 91. SWEDISH ORPHAN BIOVITRUM AB Description and Business Overview

Table 92. SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. SWEDISH ORPHAN BIOVITRUM AB Eftrenonacog Alfa Product

Table 94. SWEDISH ORPHAN BIOVITRUM AB Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Eftrenonacog Alfa Distributors List

Table 98. Eftrenonacog Alfa Customers List

Table 99. Eftrenonacog Alfa Market Trends

Table 100. Eftrenonacog Alfa Market Drivers

Table 101. Eftrenonacog Alfa Market Challenges

Table 102. Eftrenonacog Alfa Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Eftrenonacog Alfa

Figure 2. Global Eftrenonacog Alfa Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Eftrenonacog Alfa Market Share by Type: 2024 & 2031

Figure 4. 250IU Product Picture

Figure 5. 500IU Product Picture

Figure 6. 1000IU Product Picture

Figure 7. 2000IU Product Picture

Figure 8. Global Eftrenonacog Alfa Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Eftrenonacog Alfa Market Share by Application: 2024 & 2031

Figure 10. Hemophilia

Figure 11. Surgical Bleeding

Figure 12. Long-term Bleeding Prevention

Figure 13. Global Eftrenonacog Alfa Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Eftrenonacog Alfa Market Size (2020-2031) & (US$ Million)

Figure 15. Global Eftrenonacog Alfa Sales (2020-2031) & (K Units)

Figure 16. Global Eftrenonacog Alfa Average Price (US$/Unit) & (2020-2031)

Figure 17. Eftrenonacog Alfa Report Years Considered

Figure 18. Eftrenonacog Alfa Sales Share by Manufacturers in 2024

Figure 19. Global Eftrenonacog Alfa Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Eftrenonacog Alfa Players: Market Share by Revenue in Eftrenonacog Alfa in 2024

Figure 21. Eftrenonacog Alfa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Eftrenonacog Alfa Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Eftrenonacog Alfa Sales Market Share by Country (2020-2031)

Figure 24. North America Eftrenonacog Alfa Revenue Market Share by Country (2020-2031)

Figure 25. United States Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Eftrenonacog Alfa Sales Market Share by Country (2020-2031)

Figure 28. Europe Eftrenonacog Alfa Revenue Market Share by Country (2020-2031)

Figure 29. Germany Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Eftrenonacog Alfa Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Eftrenonacog Alfa Revenue Market Share by Region (2020-2031)

Figure 36. China Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Eftrenonacog Alfa Sales Market Share by Country (2020-2031)

Figure 44. Latin America Eftrenonacog Alfa Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Eftrenonacog Alfa Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Eftrenonacog Alfa Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Eftrenonacog Alfa Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Eftrenonacog Alfa by Type (2020-2031)

Figure 54. Global Revenue Market Share of Eftrenonacog Alfa by Type (2020-2031)

Figure 55. Global Eftrenonacog Alfa Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Eftrenonacog Alfa by Application (2020-2031)

Figure 57. Global Revenue Market Share of Eftrenonacog Alfa by Application (2020-2031)

Figure 58. Global Eftrenonacog Alfa Price (US$/Unit) by Application (2020-2031)

Figure 59. Eftrenonacog Alfa Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Hemophilia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Human Chorionic Gonadotropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Coagulation Factor IX Market Research Report 2025

Global Human Coagulation Factor IX Market Research Report 2024

Global Recombinant Coagulation Factor Concentrate Market Research Report 2024

Global Eptacog Alfa rFVIIa Market Research Report 2025

Eptacog Alfa Recombinant Human Coagulation Factor VIIa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024

Fc Fusion Protein for Haemophilia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Human Tumor Necrosis Factor α ReceptorⅡ IgG Fc Fusion Protein for Injection Market Research Report 2024

Alprolix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Plasma Proteins Market Insights Forecast to 2030

Global Therapeutic Fc Fusion Protein Market Research Report 2025

Cryoprecipitated Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fc Fusion Protein Drug Market Research Report 2025

Recombinant Protein Therapeutics Market

Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fusion Protein Drug Market Research Report 2025

Recombinant Non Glycosylated Proteins Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions